inadequate and unsystematic in India and there is a vast scope for improvement …

Novartis spent nearly 15 years seeking a patent in India for Glivec. That quest reached its dead end, at last, on April … 1st. India's Supreme Court rejected the Swiss drugmaker's patent. It represents critical issues related to intellectual … pharmaceutical trade in India in the future, as well as India's role as the “Pharmacy of the Developing World”. India's verdict is …

. India ranks third in terms of volume of medicines produced, and is a major global supplier of generic medicines. However …, India depends heavily on the import of several raw materials used to produce some of these medicines. Main Body: This paper … dependence, especially regarding the secure access to essential medicines. India needs a conducive ecosystem to capitalize on the …

central to this debate, especially the case of India, which did not recognize product patents in pharmaceuticals before TRIPS …-introduction of product patent protection in pharmaceuticals in India in line with the TRIPS agreement, considerable speculation and … and evolved as a major pharmaceuticals manufacturer and exporter. During the AIDS pandemic when patented products were …